//

 
Founders need to be thinking about an exit for their startup “from the get go” to ensure it reaches its full potential, OneVentures managing director Dr Paul Kelly says.
 
Kelly was behind the recent $280 million exit of head lice treatment biotech company Hatchtech (growth/lice-killer-biotech-exit-comes-up-to-scratch-for-blue-sky/2015092315570.html) and says that as much focus
Read more… (http://ift.tt/1QqV8Aq)

from News http://ift.tt/1QqV8Aq